Immunocore Holdings Plc (IMCR)
28.62
+0.82
(+2.97%)
USD |
NASDAQ |
Jun 09, 16:00
28.62
0.00 (0.00%)
After-Hours: 20:00
Immunocore Holdings EPS Diluted (Quarterly) : 0.2446 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1055 |
| NuCana Plc | -1.28 |
| Mereo BioPharma Group Plc | -0.0418 |
| Compass Pathways Plc | -0.3044 |
| Genflow Biosciences Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.95M |
| Revenue (Quarterly) | 106.50M |
| Total Expenses (Quarterly) | 93.55M |
| Enterprise Value | 1.003B |
| Gross Profit Margin (Quarterly) | 98.70% |
| Profit Margin (Quarterly) | 12.16% |
| Earnings Yield | -1.96% |
| Normalized Earnings Yield | -2.734 |